FierceBiotech: Viral protein shows early promise for treating graft vs. host disease in stem cell transplant patients Viral protein shows early promise for treating graft vs. host disease in stem cell transplant patients Graft-versus-host disease (GVHD) following liver transplantation remains a rare but devastating complication, characterised by donor immunocompetent cells initiating an immune attack against host ...

Context Explanation

Patients receiving post-transplant cyclophosphamide to prevent graft-versus-host disease have lower risk for bronchiolitis obliterans syndrome. The American Journal of Managed Care: The Pathophysiology of Chronic Graft-Vs -Host Disease (cGVHD) and the Role of CSF1R Sergio A. Giralt, MD, discusses how the pathophysiology of chronic graft-vs-host disease involves complex immune dysregulation, with CSF1R playing a crucial role in driving the differentiation of ... The Pathophysiology of Chronic Graft-Vs -Host Disease (cGVHD) and the Role of CSF1R Healio: More research needed to better discern differences in graft-versus-host disease, dry eye More research needed to better discern differences in graft-versus-host disease, dry eye